These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Severe upper gastrointestinal bleeding during treatment with rofecoxib for osteoarthritis. Caroli A; Monica F Am J Gastroenterol; 2001 May; 96(5):1663-5. PubMed ID: 11374736 [No Abstract] [Full Text] [Related]
3. Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib. Gornet JM; Hassani Z; Modiglian R; Lémann M Am J Gastroenterol; 2002 Dec; 97(12):3209-10. PubMed ID: 12492220 [No Abstract] [Full Text] [Related]
4. Celecoxib and rofecoxib. Brinker AD; Bonnel RA; Feight AG; Nourjah P J Am Dent Assoc; 2001 Nov; 132(11):1502, 1504. PubMed ID: 11806062 [No Abstract] [Full Text] [Related]
5. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. Langman MJ; Jensen DM; Watson DJ; Harper SE; Zhao PL; Quan H; Bolognese JA; Simon TJ JAMA; 1999 Nov; 282(20):1929-33. PubMed ID: 10580458 [TBL] [Abstract][Full Text] [Related]
6. Haemorrhagic gastritis and bleeding following rofecoxib administration. Tuccori M; Martini G; Giustini SE; Salvetti A; Blandizzi C; Del Tacca M Clin Exp Rheumatol; 2005; 23(5):727-8. PubMed ID: 16173261 [No Abstract] [Full Text] [Related]
7. Rofecoxib: a possible cause of acute colitis. Freitas J; Farricha V; Nascimento I; Borralho P; Paramés A J Clin Gastroenterol; 2002 Apr; 34(4):451-3. PubMed ID: 11907361 [TBL] [Abstract][Full Text] [Related]
8. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. Bombardier C; Laine L; Reicin A; Shapiro D; Burgos-Vargas R; Davis B; Day R; Ferraz MB; Hawkey CJ; Hochberg MC; Kvien TK; Schnitzer TJ; N Engl J Med; 2000 Nov; 343(21):1520-8, 2 p following 1528. PubMed ID: 11087881 [TBL] [Abstract][Full Text] [Related]
9. A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects. Hunt RH; Bowen B; Mortensen ER; Simon TJ; James C; Cagliola A; Quan H; Bolognese JA Am J Med; 2000 Aug; 109(3):201-6. PubMed ID: 10974182 [TBL] [Abstract][Full Text] [Related]
10. Rofecoxib and the risk of adverse upper gastrointestinal effects. Whitney E JAMA; 2000 Apr; 283(15):1960; author reply 1961. PubMed ID: 10789660 [No Abstract] [Full Text] [Related]
11. Rofecoxib and the risk of adverse upper gastrointestinal effects. Freston J JAMA; 2000 Apr; 283(15):1960; author reply 1961. PubMed ID: 10789659 [No Abstract] [Full Text] [Related]
12. COX-2 inhibitors--a lesson in unexpected problems. Drazen JM N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947 [No Abstract] [Full Text] [Related]
13. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data. Layton D; Heeley E; Hughes K; Shakir SA Rheumatology (Oxford); 2003 May; 42(5):622-31. PubMed ID: 12709537 [TBL] [Abstract][Full Text] [Related]
15. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered]. MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036 [No Abstract] [Full Text] [Related]
16. Rofecoxib for osteoarthritis and pain. Med Lett Drugs Ther; 1999 Jul; 41(1056):59-61. PubMed ID: 10436769 [No Abstract] [Full Text] [Related]
17. Upper gastrointestinal toxicity of rofecoxib and naproxen. Gupta S N Engl J Med; 2001 May; 344(18):1398; author reply 1398-9. PubMed ID: 11336057 [No Abstract] [Full Text] [Related]
18. Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective. Marshall JK; Pellissier JM; Attard CL; Kong SX; Marentette MA Pharmacoeconomics; 2001; 19(10):1039-49. PubMed ID: 11735672 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibitor celecoxib: a possible cause of gastropathy and hypoprothrombinemia. Linder JD; Mönkemüller KE; Davis JV; Wilcox CM South Med J; 2000 Sep; 93(9):930-2. PubMed ID: 11005360 [TBL] [Abstract][Full Text] [Related]